Literature DB >> 25577410

[Microsurgical anatomy of perforating branches of anterior communicating artery].

H Ego1, H N'Da2, L Viart2, P Foulon2, D Le Gars2, E Havet2, J Peltier2.   

Abstract

INTRODUCTION: The anterior communicating artery (ACoA) gives perforating branches to the optic chiasma, the hypothalamus and the corpus callosum. Perforating branches are variable (number, direction). Nevertheless, their knowledge is crucial during surgery of this area to spare injuries leading to ischemic post-operative complications.
OBJECTIVE: The objective was to update the anatomical knowledge about perforating branches of the ACoA.
METHODS: The study was led on a series of seven brains taken from human cadavers. An injection of latex neoprene was performed for every case. The region of interest was observed under operating microscope. Were examined: the length of the ACoA, its diameter, its orientation, its configuration and perforating branches (number and areas).
RESULTS: Three cases on five presented with an anatomical variation at the level of the ACoA. The average length of AcoA was 2.1 millimeters (min: 2, max: 2.2). The average diameter of the ACoA was 1.67 mm (min: 1.1, max: 2.1). The average number of perforating branches was 4.2 (min: 2, max: 6). The presence of a median artery of the corpus callosum seemed to correlated with a low number of perforating branches. Branches supplying the optic chiasma seemed to be more numerous.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anatomie; Anatomy; Anterior communicating artery; Artère communicante antérieure; Branches perforantes; Injection; Perforating branches

Mesh:

Year:  2014        PMID: 25577410     DOI: 10.1016/j.morpho.2014.11.001

Source DB:  PubMed          Journal:  Morphologie        ISSN: 1286-0115


  1 in total

1.  Ischemic stroke in the combined territories of the septum pellucidum and the cingulate gyrus: A case report and literature review.

Authors:  Sui-Yi Xu; Fu-Chun Xi; Xiao-Wei Wu; Chang-Xin Li
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.